Detalhe da pesquisa
1.
Sitravatinib combined with PD-1 blockade enhances cytotoxic T-cell infiltration by M2 to M1 tumor macrophage repolarization in esophageal adenocarcinoma.
Carcinogenesis;
45(4): 210-219, 2024 Apr 12.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38019590
2.
Targeting interleukin-6 as a treatment approach for peritoneal carcinomatosis.
J Transl Med;
22(1): 402, 2024 Apr 30.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38689325
3.
Characterizing the Immune Environment in Peritoneal Carcinomatosis: Insights for Novel Immunotherapy Strategies.
Ann Surg Oncol;
31(3): 2069-2077, 2024 Mar.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37996643
4.
Synchronous Well-Differentiated Papillary Mesothelioma and Endometrioid Adenocarcinoma Arising From Endometriosis.
Oncology (Williston Park);
38(5): 191-193, 2024 May 13.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38776516
5.
Assessing the long-term priorities of pancreaticoduodenectomy survivors.
HPB (Oxford);
26(5): 703-710, 2024 May.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38443235
6.
Defining the Values and Quality of Life of Cancer Survivors Following Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy: An International Survey Study.
Ann Surg Oncol;
30(12): 7825-7832, 2023 Nov.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37535272
7.
CSF-1R inhibitor, pexidartinib, sensitizes esophageal adenocarcinoma to PD-1 immune checkpoint blockade in a rat model.
Carcinogenesis;
43(9): 842-850, 2022 10 22.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35552655
8.
A blood-based circulating microbial metagenomic panel for early diagnosis and prognosis of oesophageal adenocarcinoma.
Br J Cancer;
127(11): 2016-2024, 2022 11.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36097175
9.
Advanced Care Planning Prior to Oncologic Surgery: An Assessment of Utilization and Implications.
Ann Surg Oncol;
2024 May 16.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38755343
10.
ASO Visual Abstract: Defining the Values and Quality of Life of Cancer Survivors Following Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy: An International Survey Study.
Ann Surg Oncol;
30(12): 7871, 2023 11.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37715111
11.
Oncologic Risk Stratification Following Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Appendiceal Carcinomatosis.
Ann Surg Oncol;
23(5): 1587-93, 2016 May.
Artigo
em Inglês
| MEDLINE
| ID: mdl-26744106
12.
Minimally Invasive Hepatopancreatobiliary Surgery at a Large Regional Health System: Assessing the Safety of Program Expansion.
Am Surg;
90(1): 85-91, 2024 Jan.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37578387
13.
Navigating Precision Oncology: Insights from an Integrated Clinical Data and Biobank Repository Initiative across a Network Cancer Program.
Cancers (Basel);
16(4)2024 Feb 12.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38398150
14.
Significance of serum tumor marker levels in peritoneal carcinomatosis of appendiceal origin.
Ann Surg Oncol;
20(2): 506-14, 2013 Feb.
Artigo
em Inglês
| MEDLINE
| ID: mdl-22941175
15.
Extensive cytoreductive surgery for appendiceal carcinomatosis: morbidity, mortality, and survival.
Ann Surg Oncol;
20(4): 1056-62, 2013 Apr.
Artigo
em Inglês
| MEDLINE
| ID: mdl-23456385
16.
The Influence of the Microbiome on Immunotherapy for Gastroesophageal Cancer.
Cancers (Basel);
15(18)2023 Sep 05.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37760397
17.
Comprehensive Cost Implications of Commercially Available Noninvasive Colorectal Cancer Screening Modalities.
J Am Coll Surg;
237(3): 465-472, 2023 09 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37219020
18.
Regional Immunotherapy for Peritoneal Carcinomatosis in Gastroesophageal Cancer: Emerging Strategies to Re-Condition a Maladaptive Tumor Environment.
Cancers (Basel);
15(20)2023 Oct 23.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37894473
19.
Early postoperative intraperitoneal chemotherapy following cytoreductive surgery for appendiceal mucinous neoplasms with isolated peritoneal metastasis.
Dis Colon Rectum;
55(4): 407-15, 2012 Apr.
Artigo
em Inglês
| MEDLINE
| ID: mdl-22426264
20.
Localized Intra-Cavitary Therapy to Drive Systemic Anti-Tumor Immunity.
Front Immunol;
13: 846235, 2022.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35222439